OM
Opaleye Management’s Protara Therapeutics TARA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59M | Sell |
855,000
-875,000
| -51% | -$2.65M | 0.52% | 31 |
|
|
2025
Q1 | $7.37M | Sell |
1,730,000
-95,000
| -5% | -$405K | 1.64% | 12 |
|
|
2024
Q4 | $9.64M | Buy |
1,825,000
+143,846
| +9% | +$760K | 1.69% | 13 |
|
|
2024
Q3 | $3.08M | Sell |
1,681,154
-623,108
| -27% | -$1.14M | 0.51% | 31 |
|
|
2024
Q2 | $5.3M | Sell |
2,304,262
-388,332
| -14% | -$893K | 1.21% | 26 |
|
|
2024
Q1 | $10.8M | Hold |
2,692,594
| – | – | 2.35% | 14 |
|
|
2023
Q4 | $5.05M | Hold |
2,692,594
| – | – | 1.34% | 21 |
|
|
2023
Q3 | $4.5M | Hold |
2,692,594
| – | – | 1.46% | 18 |
|
|
2023
Q2 | $6.44M | Hold |
2,692,594
| – | – | 1.54% | 16 |
|
|
2023
Q1 | $8.08M | Hold |
2,692,594
| – | – | 2.42% | 10 |
|
|
2022
Q4 | $7.22M | Sell |
2,692,594
-15,473
| -0.6% | -$41.5K | 2.51% | 11 |
|
|
2022
Q3 | $7.99M | Buy |
2,708,067
+23,900
| +0.9% | +$70.5K | 3.3% | 8 |
|
|
2022
Q2 | $8.89M | Buy |
2,684,167
+10,136
| +0.4% | +$33.6K | 4% | 7 |
|
|
2022
Q1 | $13.7M | Buy |
2,674,031
+24,031
| +0.9% | +$123K | 4.24% | 8 |
|
|
2021
Q4 | $18M | Buy |
2,650,000
+91,528
| +4% | +$622K | 3.82% | 8 |
|
|
2021
Q3 | $17.7M | Hold |
2,558,472
| – | – | 3.31% | 9 |
|
|
2021
Q2 | $24.9M | Hold |
2,558,472
| – | – | 4.14% | 8 |
|
|
2021
Q1 | $40.3M | Hold |
2,558,472
| – | – | 5.92% | 3 |
|
|
2020
Q4 | $61.9M | Hold |
2,558,472
| – | – | 8.09% | 2 |
|
|
2020
Q3 | $43.1M | Buy |
2,558,472
+350,000
| +16% | +$5.89M | 8.42% | 2 |
|
|
2020
Q2 | $64.8M | Hold |
2,208,472
| – | – | 13.08% | 1 |
|
|
2020
Q1 | $52.1M | Buy |
2,208,472
+2,020,328
| +1,074% | +$47.7M | 13.82% | 1 |
|
|
2019
Q4 | $75K | Buy |
188,144
+134,144
| +248% | +$53.5K | 0.01% | 46 |
|
|
2019
Q3 | $14K | Buy |
+54,000
| New | +$14K | 0.01% | 49 |
|